# Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/omalizumab-updosing-allows-disease-activity-control-in-patients-with-refractory/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Laia Curto‐Barredo,Jorge Spertino,Ignasi Figueras‐Nart,V. Expósito‐Serrano,Antonio Guilabert,Gemma Melé‐Ninot,Xavier Cubiró,Montserrat Bonfill‐Ortí,J. Garcias‐Ladaria,Manuel Alcántara Villar,Xavier García-Navarro,I. Bielsa-Marsol,M. Sagué Vilavella,G. Aparicio,Carola Baliu‐Piqué,Airam Alvarez,Nuria Lamas-Doménech,X. Duran-Jordà,E. Serra‐Baldrich,Ana M. Giménez‐Arnau |
| Citations | 65 |
| DOI | 10.1111/bjd.16379 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2793609975 |
| PMID | 29368377 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Laia Curto‐Barredo](https://scholariq.org/researchers/laia-curto-barredo/)

## Paper journal

- [British Journal of Dermatology](https://scholariq.org/journals/british-journal-of-dermatology/)

## Paper primary topic

- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

## Paper topics

- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.